---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-038305"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2026-08-14T20:06:09+00:00"
generated_at: "2026-08-14T20:12:07.832126+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ENvue Medical stockholders approve reverse stock split ratio range 1-for-2 to 1-for-50

## Summary
- Stockholders approved reverse stock split: 3,847,974 for, 1,062,981 against, 19,288 abstain.
- Board authorized to set ratio between 1-for-2 and 1-for-50, to be announced publicly, within one year.
- Adjournment proposal passed (4,199,681 for) but not needed; no motion made.
- Special meeting held Aug 14, 2026; no other matters voted on.

## SEC filing metadata
- accession: 0001493152-26-038305
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2026-08-14T20:06:09+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315226038305/0001493152-26-038305-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315226038305/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-038305
- JSON: https://secwatch.observer/filing/0001493152-26-038305.json
- Plain text: https://secwatch.observer/filing/0001493152-26-038305.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.